Because the CONCERTA tablet is nondeformable and does not appreciably change in condition within the GI tract, CONCERTA must not ordinarily be administered to patients with preexisting critical gastrointestinal narrowing (pathologic or iatrogenic, such as: esophageal motility disorders, compact bowel inflammatory disorder, "quick intestine" syndrom